Stocks

Amgen Stake Surges 89.9% as Saudi Central Bank Increases Holdings

Guavy AI Editorial Team Published September 6, 2026

Instruments

AMGN

Saudi Central Bank's stake in Amgen Inc. (NASDAQ:AMGN) has increased by 89.9% in the second quarter, according to a recent disclosure with the Securities and Exchange Commission.

The fund now owns 37,735 shares of the medical research company's stock after purchasing an additional 17,859 shares during the period.

The value of Saudi Central Bank's holdings in Amgen was $13,665,000 as of its most recent SEC filing.

Venezuela Signs Major Oil Deals with US Companies Amid Industry Risks

Stocks 5m ago

Saudi Central Bank Ups Stake in Coca-Cola

Stocks 5m ago

HB Wealth Management Boosts Stake in Coca-Cola to Over $56 Million

Disclaimer: Guavy is a data and market intelligence provider, not an investment adviser. The information, signals, and market analysis provided by the Guavy API and related services are for informational purposes only and are not intended as financial advice, investment recommendations, or an endorsement of any particular trading strategy. Trading in volatile markets, including cryptocurrency, carries significant risk and may not be suitable for all investors. Past performance is not indicative of future results. Users should consult with a qualified financial professional before making any investment decisions. Guavy makes no guarantee of trading profits or financial returns.

GUAVY

Market sentiment intelligence for apps, funds & agents

Location

729 55 Ave SW
Calgary AB T2V 0G4
Canada

Navigate

Markets

Resources

Terms Privacy Policy